Apollo Funds to Acquire Covis Pharma from Cerberus

Biogen Acquires Apellis Pharmaceuticals

March 31, 2026

Healthcare Services

Biogen entered into a definitive agreement to acquire Apellis Pharmaceuticals in a ~$5.6 billion cash deal ($41 per share) that also includes contingent value rights (CVRs) tied to SYFOVRE sales performance. The transaction closed in May 2026 and made Apellis a wholly owned subsidiary of Biogen, adding commercial products EMPAVELI and SYFOVRE to Biogen’s immunology/rare disease portfolio and strengthening its expansion into nephrology.

Cerberus Capital Management Completes Acquisition of Vivace International

February 18, 2026

Aerospace & Defense

An affiliate of Cerberus Capital Management, L.P. has completed the full acquisition of Vivace International Corporation. Cerberus previously made a strategic growth investment in Vivace in 2024 and has since supported engineering and manufacturing capability expansion to scale production for U.S. defense and spaceflight programs.

Azurity Pharmaceuticals Acquires Covis Pharma

March 14, 2025

Pharmaceuticals

Azurity Pharmaceuticals has completed its acquisition of Covis Group S.à r.l. (Covis Pharma) from existing investors, making Covis a wholly owned subsidiary of Azurity. The deal expands Azurity's therapeutic portfolio across multiple complex dosage forms and broadens its global footprint, with the combined company serving 50+ countries and employing more than 800 colleagues.

ATHAGORAS Group Acquires CSO Pharma Consulting GmbH

November 18, 2024

Healthcare Services

ATHAGORAS Group has acquired CSO Pharma Consulting GmbH to expand and internationalize its pharmacovigilance, medical affairs, quality management and GDP consulting capabilities across the pharma and healthcare sectors. The deal adds a specialized provider of PV and regulatory support to ATHAGORAS' life‑sciences services platform while CSO retains focus on organic growth and continuity for clients and employees.

Apollo Funds to Acquire Majority Stake in Novolex

February 14, 2022

Packaging

Funds managed by Apollo affiliates have entered into a definitive agreement to acquire a majority stake in Novolex from funds managed by Carlyle, with Carlyle retaining a minority interest. Novolex, a leading sustainable packaging manufacturer headquartered in Hartsville, South Carolina with more than 10,000 employees and 57 manufacturing facilities, will look to leverage Apollo's resources to expand customer relationships, sustainability initiatives and product innovation.

Covis Group Acquires AMAG Pharmaceuticals

November 16, 2020

Pharmaceuticals

Covis Group S.à r.l. completed a cash tender offer and merger to acquire AMAG Pharmaceuticals, Inc. for $13.75 per share, taking AMAG private and delisting its NASDAQ shares. The acquisition adds AMAG’s marketed products (including Feraheme and Makena) and development-stage assets in women’s health and hematology/oncology to Covis’ specialty pharma portfolio, supported by financing from Capital One and investment funds managed by HPS Investment Partners.